Grants paid by Ben and Rose Cole Charitable Pria Foundation
EIN 45-3513929 · Milton, MA · Form 990-PF, Part XV · NTEE T20
Ben and Rose Cole Charitable Pria Foundation of Milton, MA (EIN 45-3513929) reported 18 grants paid totaling $3,331,250 to 7 recipients in tax years 2019–2024, on Form 990-PF, Part XV. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.
Grants paid
$3,331,250
18 grants
Recipients
7
distinct organizations
Tax years
2019–2024
5 filings in the corpus
By tax year
| Tax year | Grants paid | Amount paid | Approved for future |
|---|---|---|---|
| 2019 | 4 | $475,000 | — |
| 2021 | 4 | $625,000 | — |
| 2022 | 4 | $600,000 | — |
| 2023 | 2 | $425,000 | — |
| 2024 | 4 | $1,206,250 | — |
Top recipients
The 7 recipients receiving the most from Ben and Rose Cole Charitable Pria Foundation, by grants paid, out of 7 distinct recipients.
| Recipient | Match | Location | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| Memorial Sloan Kettering Cancer Center 13-1924236 | B | New York, NY | 5 | $1,425,000 | 2024 |
| University of Texas Md Anderson Cancer Center | U | Houston, TX | 3 | $575,000 | 2022 |
| Md Anderson | U | Houston, TX | 1 | $450,000 | 2024 |
| New York University Medical School | U | New York, NY | 2 | $375,000 | 2022 |
| New York University 13-5562308 | C | New York, NY | 1 | $250,000 | 2024 |
| Johns Hopkins University | U | Baltimore, MD | 1 | $150,000 | 2019 |
| Boston University General Surgical Inc 04-3265008 | C | Boston, MA | 5 | $106,250 | 2024 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Every grant
All 18 grant rows this organization reported, most recent first.
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2024 | Memorial Sloan Kettering Cancer Center New York, NY | B | $500,000 | paid | TO PROMOTE PANCREATIC CANCER RESEARCH AND EALY DETECTION | 202402309349100200 |
| 2024 | Md Anderson Houston, TX | U | $450,000 | paid | TO PROMOTE PACREATIC CANCER RESEARCH AND EARLY DETECTION | 202402309349100200 |
| 2024 | New York University New York, NY | C | $250,000 | paid | TO PROMOTE PANCREATIC CANCER RESEARCH AND EARLY DETECTION | 202402309349100200 |
| 2024 | Boston University General Surgial Inc Boston, MA | D | $6,250 | paid | TO PROMOTE PANCREATIC CANCER RESEARCH AND EARLY DETECTION. | 202402309349100200 |
| 2023 | Memorial Sloan Kettering Cancer Center New York, NY | B | $400,000 | paid | TO PROMOTE PANCREATIC CANCER RESEARCH AND EALY DETECTION | 202312439349100701 |
| 2023 | Boston University General Surgial Inc Boston, MA | D | $25,000 | paid | TO PROMOTE PANCREATIC CANCER RESEARCH AND EARLY DETECTION. | 202312439349100701 |
| 2022 | Memorial Sloan Kettering Cancer Center New York, NY | B | $200,000 | paid | TO PROMOTE PANCREATIC CANCER RESEARCH AND EARLY DIAGNOSIS | 202242849349100529 |
| 2022 | New York University Medical School New York, NY | U | $200,000 | paid | TO PROMOTE PANCREATIC CANCER RESERACH AND EARLY DETECTION | 202242849349100529 |
| 2022 | University of Texas Md Anderson Cancer Center Houston, TX | U | $175,000 | paid | TO PROMOTE PANCREATIC CANCER RESERCH AND EARLY DETECTION | 202242849349100529 |
| 2022 | Boston University General Surgical Inc Boston, MA | C | $25,000 | paid | TO FURTHER PANCREATIC CANCER RESEARCH | 202242849349100529 |
| 2021 | University of Texas Md Anderson Cancer Center Houston, TX | U | $250,000 | paid | TO PROMOTE PANCREATIC CANCER RESERCH AND EARLY DETECTION | 202113199349103471 |
| 2021 | Memorial Sloan Kettering Cancer Center New York, NY | B | $175,000 | paid | TO PROMOTE PANCREATIC CANCER RESEARCH AND EARLY DIAGNOSIS | 202113199349103471 |
| 2021 | New York University Medical School New York, NY | U | $175,000 | paid | TO PROMOTE PANCREATIC CANCER RESERACH AND EARLY DETECTION | 202113199349103471 |
| 2021 | Boston University General Surgical Inc Boston, MA | C | $25,000 | paid | TO FURTHER PANCREATIC CANCER RESEARCH | 202113199349103471 |
| 2019 | University of Texas Md Anderson Cancer Center Houston, TX | U | $150,000 | paid | TO PROMOTE | 201912609349100201 |
| 2019 | Johns Hopkins University Baltimore, MD | U | $150,000 | paid | TO PROMOTE PANCREATIC CANCER RESEARCH | 201912609349100201 |
| 2019 | Memorial Sloan Kettering Cancer Center New York, NY | B | $150,000 | paid | TO PROMOTE PANCREATIC CANCER RESEARCH AND EARLY DIAGNOSIS | 201912609349100201 |
| 2019 | Boston University General Surgical Inc Boston, MA | C | $25,000 | paid | TO FURTHER PANCREATIC CANCER RESEARCH | 201912609349100201 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Source filings
Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.
| Form | Tax year | Period end | Filed | Schema | IRS OBJECT_ID |
|---|---|---|---|---|---|
| 990PF | 2024 | 2024-06-30 | not stated | 2023v5.1 | 202402309349100200 |
| 990PF | 2023 | 2023-06-30 | not stated | 2022v5.0 | 202312439349100701 |
| 990PF | 2022 | 2022-06-30 | not stated | 2021v4.2 | 202242849349100529 |
| 990PF | 2021 | 2021-06-30 | not stated | 2020v4.1 | 202113199349103471 |
| 990PF | 2019 | 2019-06-30 | not stated | 2018v3.1 | 201912609349100201 |
Derived from IRS Form 990-PF e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/453513929.json.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.